17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
This is the third of our series of blog posts on the Office of Management and Budget’s (OMB) July 1...
Read More >
A group of three major drug distributors—McKesson, AmerisourceBergen, and Cardinal Health—are in t...
Read More >
Setting up a new business in Ontario can raise legal questions and concerns about recruiting and hir...
Read More >
Valid arbitration agreements may prevent class notices from being sent to employees that would other...
Read More >
Financial institutions M&A sector trends: consumer finance — H2 2019 and outlook for 2020 - Financ...
Read More >
In a major victory for franchisors, a panel of the Ninth Circuit recently held that McDonald's Corpo...
Read More >